Maintenance of luminal NADPH in the endoplasmic reticulum promotes the survival of human neutrophil granulocytes

FEBS Letters

Volumn 582, Issue 13, 2008, Pages 1809-1815

  Kardon, Tamás ^a   Senesi, Silvia ^b   Marcolongo, Paola ^b   Legeza, Balázs ^a   Bánhegyi, Gábor ^a,b   Mandl, József ^a   Fulceri, Rosella ^b   Benedetti, Angelo ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

11 Hydroxysteroid dehydrogenase type 1; Apoptosis; Glucocorticoid; Glucose 6 phosphate transporter; Hexose 6 phosphate dehydrogenase

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTISONE; GLUCOSE 6 PHOSPHATE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HYDROCORTISONE; OXIDOREDUCTASE; PHOSPHATE TRANSPORTER; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIVER MICROSOME; MICROSOME; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ANIMALS; APOPTOSIS; BIOLOGICAL TRANSPORT; CARBOHYDRATE DEHYDROGENASES; CELL SURVIVAL; ENDOPLASMIC RETICULUM; GLUCOSE-6-PHOSPHATE; HUMANS; HYDROCORTISONE; MICROSOMES; NADP; NEUTROPHILS; RATS;

EID: 44649127360     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.04.045     Document Type: Article

References (44)

1. van Schaftingen E., and Gerin I. The glucose-6-phosphatase system. Biochem. J. 362 (2002) 513-532
2. Nordlie R.C., Foster J.D., and Lange A.J. Regulation of glucose production by the liver. Annu. Rev. Nutr. 19 (1999) 379-406
3. Piccirella S., Czegle I., Lizák B., Margittai E., Senesi S., Papp E., Csala M., Fulceri R., Csermely P., Mandl J., Benedetti A., and Bánhegyi G. Uncoupled redox systems in the lumen of the endoplasmic reticulum. Pyridine nucleotides stay reduced in an oxidative environment. J. Biol. Chem. 281 (2006) 4671-4677
4. Czegle I., Piccirella S., Senesi S., Csala M., Mandl J., Bánhegyi G., Fulceri R., and Benedetti A. Cooperativity between 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase is based on a common pyridine nucleotide pool in the lumen of the endoplasmic reticulum. Mol. Cell. Endocrinol. 248 (2005) 24-25
5. Atanasov A.G., Nashev L.G., Schweizer R.A., Frick C., and Odermatt A. Hexose-6-phosphate dehydrogenase determines the reaction direction of 11β-hydroxysteroid dehydrogenase type 1 as an oxidoreductase. FEBS Lett. 571 (2004) 129-133
6. Hewitt K.N., Walker E.A., and Stewart P.M. Hexose-6-phosphate dehydrogenase and redox control of 11β-hydroxysteroid dehydrogenase type 1 activity. Endocrinology 146 (2004) 2539-2543
7. Bujalska I.J., Draper N., Michailidou Z., Tomlinson J.W., White P.C., Chapman K.E., Walker E.A., and Stewart P.M. Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11β-hydroxysteroid dehydrogenase type 1. J. Mol. Endocrinol. 34 (2005) 675-684
8. Seckl J.R., and Walker B.R. 11β-Hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory. Trends Endocrinol. Metab. 15 (2004) 418-424
9. Draper N., and Stewart P.M. 11β-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. J. Endocrinol. 186 (2005) 251-271
10. Tomlinson J.W., Walker E.A., Bujalska I.J., Draper N., Lavery G.G., Cooper M.S., Hewison M., and Stewart P.M. 11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response. Endocr. Rev. 25 (2004) 831-866
11. Kuijpers T.W. Clinical symptoms and neutropenia: the balance of neutrophil development, functional activity, and cell death. Eur. J. Pediatr. 161 Suppl. 1 (2002) S75-S82
12. Chen L.Y., Shieh J.J., Lin B., Pan C.J., Gao J.L., Murphy P.M., Roe T.F., Moses S., Ward J.M., Lee E.J., Westphal H., Mansfield B.C., and Chou J.Y. Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter. Hum. Mol. Genet. 12 (2003) 2547-2558
13. Kim S.Y., Nguyen A.D., Gao J.L., Murphy P.M., Mansfield B.C., and Chou J.Y. Bone marrow-derived cells require a functional glucose 6-phosphate transporter for normal myeloid functions. J. Biol. Chem. 281 (2006) 28794-28801
14. Yiu W.H., Pan C.J., Allamarvdasht M., Kim S.Y., and Chou J.Y. Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice. Gene Ther. 14 (2007) 219-226
15. Herling A.W., Burger H.J., Schwab D., Hemmerle H., Below P., and Schubert G. Pharmacodynamic profile of a novel inhibitor of the hepatic glucose-6-phosphatase system. Am. J. Physiol. 274 (1998) G1087-G1093
16. Khan A., Ling Z.C., Pukk K., Herling A.W., Landau B.R., and Efendic S. Effects of 3-mercaptopicolinic acid and a derivative of chlorogenic acid (S-3483) on hepatic and islet glucose-6-phosphatase activity. Eur. J. Pharmacol. 349 (1998) 325-331
17. Leuzzi R., Bánhegyi G., Kardon T., Marcolongo P., Capecchi P.L., Burger H.J., Benedetti A., and Fulceri R. Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease 1b. Blood 101 (2003) 2381-2387
18. Kuijpers T.W., Maianski N.A., Tool A.T., Smit G.P., Rake J.P., Roos D., and Visser G. Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b). Blood 101 (2003) 5021-5024
19. Hjorth R., Jonsson A.K., and Vretblad P. A rapid method for purification of human granulocytes using percoll: a comparison with dextran sedimentation. J. Immunol. Methods 43 (1981) 95-101
20. Csala M., Braun L., Mile V., Kardon T., Szarka A., Kupcsulik P., Mandl J., and Bánhegyi G. Ascorbate-mediated electron transfer in protein thiol oxidation in the endoplasmic reticulum. FEBS Lett. 460 (1999) 539-543
21. Margittai E., and Bánhegyi G. Isocitrate dehydrogenase: a NADPH-generating enzyme in the lumen of the endoplasmic reticulum. Arch. Biochem. Biophys. 471 (2008) 184-190
22. Ozols J. Isolation and the complete amino acid sequence of lumenal endoplasmic reticulum glucose-6-phosphate dehydrogenase. Proc. Natl. Acad. Sci. USA 90 (1993) 5302-5306
23. Takahashi T., and Hori S.H. Intramembraneous localization of rat liver microsomal hexose-6-phosphate dehydrogenase and membrane permeability to its substrates. Biochim. Biophys. Acta 524 (1978) 262-276
24. Clarke J.L., and Mason P.J. Hexose-6-phosphate dehydrogenase: a bifunctional enzyme with broad substrate specificity and 6-phosphogluconolactonase activity. Arch. Biochem. Biophys. 415 (2003) 229-234
25. Ozols J. Lumenal orientation and post-translational modifications of the liver microsomal 11β-hydroxysteroid dehydrogenase. J. Biol. Chem. 270 (1995) 2305-2312
26. Odermatt A., Atanasov A.G., Balazs Z., Schweizer R.A., Nashev L.G., Schuster D., and Langer T. Why is 11β-hydroxysteroid dehydrogenase type 1 facing the endoplasmic reticulum lumen? Physiological relevance of the membrane topology of 11β-HSD1. Mol. Cell. Endocrinol. 248 (2006) 15-23
27. Senesi S., Marcolongo P., Kardon T., Bucci G., Sukhodub A., Burchell A., Benedetti A., and Fulceri R. Immunodetection of the expression of microsomal proteins encoded by the glucose-6-phosphate transporter gene. Biochem. J. 389 (2005) 57-62
28. Bánhegyi G., Benedetti A., Fulceri R., and Senesi S. Cooperativity between 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the lumen of the endoplasmic reticulum. J. Biol. Chem. 279 (2004) 27017-27021
29. Marcolongo P., Piccirella S., Senesi S., Wunderlich L., Gerin I., Mandl J., Fulceri R., Bánhegyi G., and Benedetti A. The glucose-6-phosphate transporter-hexose-6-phosphate dehydrogenase-11β-hydroxysteroid dehydrogenase type 1 system of the adipose tissue. Endocrinology 148 (2007) 2487-2495
30. Cheung Y.Y., Kim S.Y., Yiu W.H., Pan C.J., Jun H.S., Ruef R.A., Lee E.J., Westphal H., Mansfield B.C., and Chou J.Y. Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-β. J. Clin. Invest. 117 (2007) 784-793
31. Belkaid A., Copland I.B., Massillon D., and Annabi B. Silencing of the human microsomal glucose-6-phosphate translocase induces glioma cell death: potential new anticancer target for curcumin. FEBS Lett. 580 (2006) 3746-3752
32. Belkaid A., Currie J.C., Desgagnes J., and Annabi B. The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression. Cancer Cell Int. 6 (2006) 7
33. Belkaid A., Fortier S., Cao J., and Annabi B. Necrosis induction in glioblastoma cells reveals a new "bioswitch function for the MT1-MMP/G6PT signaling axis in proMMP-2 activation versus cell death decision. Neoplasia 9 (2007) 332-340
34. Currie J.C., Fortier S., Sina A., Galipeau J., Cao J., and Annabi B. MT1-MMP down-regulates the glucose 6-phosphate transporter expression in marrow stromal cells: a molecular link between pro-MMP-2 activation, chemotaxis, and cell survival. J. Biol. Chem. 282 (2007) 8142-8149
35. Lavery G.G., Walker E.A., Turan N., Rogoff D., Ryder J.W., Shelton J.M., Richardson J.A., Falciani F., White P.C., Stewart P.M., Parker K.L., and McMillan D.R. Deletion of hexose-6-phosphate dehydrogenase activates the unfolded protein response pathway and induces skeletal myopathy. J. Biol. Chem. 283 (2008) 8453-8461
36. Bublitz C., and Lawler C.A. The levels of nicotinamide nucleotides in liver microsomes and their possible significance to function of hexose phosphate dehydrogenase. Biochem. J. 245 (1987) 263-277
37. Hu, G.X., Lian, Q.Q., Lin, H., Latif, S.A., Morris, D.J., Hardy, M.P. and Ge, R.S. (in press) Rapid mechanisms of glucocorticoid signaling in the Leydig cell. Steroids. doi:10.1016/j.steroids.2007.12.020.
38. Löwenberg M., Verhaar A.P., van den Brink G.R., and Hommes D.W. Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression. Trends Mol. Med. 13 (2007) 158-163
39. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J. Immunol. 154 (1995) 4719-4725
40. Meagher L.C., Cousin J.M., Seckl J.R., and Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J. Immunol. 156 (1996) 4422-4428
41. Heasman S.J., Giles K.M., Ward C., Rossi A.G., Haslett C., and Dransfield I. Glucocorticoid-mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation. J. Endocrinol. 178 (2003) 29-36
42. Nittoh T., Fujimori H., Kozumi Y., Ishihara K., Mue S., and Ohuchi K. Effects of glucocorticoids on apoptosis of infiltrated eosinophils and neutrophils in rats. Eur. J. Pharmacol. 354 (1998) 73-81
43. Chang L.C., Madsen S.A., Toelboell T., Weber P.S., and Burton J.L. Effects of glucocorticoids on Fas gene expression in bovine blood neutrophils. J. Endocrinol. 183 (2004) 569-583
44. Lavery G.G., Walker E.A., Draper N., Jeyasuria P., Marcos J., Shackleton C.H., Parker K.L., White P.C., and Stewart P.M. Hexose-6-phosphate dehydrogenase knock-out mice lack 11β-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. J. Biol. Chem. 281 (2006) 6546-6551